Split History
ETFs Holding BTX »    BTX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioTime is a biotechnology company focused on the field of regenerative medicine; specifically pluripotent stem cell technology. Co. and its subsidiaries and nonconsolidated investee are developing stem cell products for research and therapeutic use. Co.'s primary therapeutic products are based on its HyStem® hydrogel technology and include Renevia®, a product to facilitate cell transplantation. Co. has also developed Hextend®, a blood plasma volume expander marketed by licensees in the U.S. and South Korea for use in surgery, emergency trauma treatment and other applications. Co.'s subsidiary, OncoCyte Corporation, is developing laboratory diagnostic tests for certain types of cancer. According to our BTX split history records, BioTime has had 1 split.
BTX split history picture
BioTime (BTX) has 1 split in our BTX split history database. The split for BTX took place on October 31, 1997. This was a 3 for 1 split, meaning for each share of BTX owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split.

When a company such as BioTime splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the BTX split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioTime shares, starting with a $10,000 purchase of BTX, presented on a split-history-adjusted basis factoring in the complete BTX split history. BTX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/30/2007
End date: 03/29/2017
Start price/share: $0.56
End price/share: $3.30
Dividends collected/share: $0.00
Total return: 489.29%
Average Annual Total Return: 19.40%
Starting investment: $10,000.00
Ending investment: $58,947.48
Years: 10.01
Date Ratio
10/31/19973 for 1
BTX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CAH Split History
CALA Split History
CAPR Split History
CASC Split History
CBIO Split History
CBLI Split History
CBM Split History
CBMX Split History
CBRX Split History
CCM Split History

German American Bancorp, Inc. (GABC)
Pacific Energy Development (PED)
The GEO Group, Inc. (GEO)
Copart, Inc. (CPRT)
HEICO Corporation (HEI)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Rosetta Genomics Ltd. (ROSG)
Condor Hospitality Trust, Inc. (CDOR)
Fibrocell Science, Inc. (FCSC)
VelocityShares Daily 2x VIX Medium Term ETN (TVIZ)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BTX Insider Buying

BTX Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.